Belgium· BE-AMP-SAM097307-00
Dipiperon 40 mg/ml
A pipamperone product containing pipamperone hydrochloride, registered in Belgium by Eumedica. The same ATC class is registered in 6 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Pipamperone is registered in 6 of 19 countries.
Countries holding a registration under ATC N05AD05 (pipamperone), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Pipamperone · ATC N05AD05
6 / 19 countries
- Belgiumprice
- Denmark
- Germany
- Japan
- Netherlands
- Switzerlandprice
Price per daily dose
What a daily dose of pipamperone costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pipamperone · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.64
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Pipamperone Hydrochloride
- Manufacturer
- Eumedica
- Country
- Belgium (BE)
- ATC code
- N05AD05
- ATC class
- Pipamperone
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
1 priced- be_apb0036566EUR 9.58
- be_apb0705376
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
41 interactions on record for pipamperone.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pipamperone · interactions on record
41 records
41 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Pipamperone in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceDIPIPERON 40 mg/ml, solution buvable en gouttesEUMEDICA PHARMACEUTICALS (ALLEMAGNE)
- NetherlandsDipiperon 40 mg/ml, druppelsEumedica Pharmaceuticals GmbH
- GermanyDipiperonEumedica / Belgium
- SwitzerlandDipiperon
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Dipiperon, Pipamperon 1 A Pharma
- Denmark · Dipiperon
- France · Dipiperon
- Greece · Dipiperon
- Luxembourg · Dipiperon
- Netherlands · Dipiperon, Pipamperon Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c573ece7-cf9f-45e7-99a0-0f04b7019899 GET /v1/drugs/c573ece7-cf9f-45e7-99a0-0f04b7019899?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral drops, solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Dipiperon 40 mg/ml",
"name_fr": "Dipiperon 40 mg/ml",
"name_nl": "Dipiperon 40 mg/ml",
"amp_code": "SAM097307-00",
"strengths": [
"48.0000",
"40.0000",
"0.5000",
"0.0500"
],
"pack_count": 1,
"substances": [
"Pipamperone Hydrochloride",
"Pipamperone",
"Methyl Parahydroxybenzoate",
"Propyl Parahydroxybenzoate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Pipamperone",
"authorisation_numbers": [
"BE097307"
]
}See everything about pipamperone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.